New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
08:51 EDTJAZZJazz Pharmaceuticals price target raised to $70 from $63 at WallachBeth
WallachBeth raised its price target for Jazz Pharmaceuticals following the company's better than expected Q4 results and reiterates a Buy rating on the stock. The firm believes Jazz's outlook leaves room for upside.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 21, 2014
12:21 EDTJAZZJazz Pharmaceuticals gets FDA okay for intravenous administration of Erwinaze
Subscribe for More Information
December 11, 2014
16:16 EDTJAZZJazz Pharmaceuticals initiates rolling NDA submission for defibrotide
Subscribe for More Information
December 9, 2014
08:31 EDTJAZZJazz, Concert say Phase 1 JZP-386 evaluation not done at highest dosage
Subscribe for More Information
December 8, 2014
07:29 EDTJAZZUBS to hold investor trip
Subscribe for More Information
07:18 EDTJAZZUBS to hold investor trip
2014 Annual West Coast Investor Trip travels on the West Coast on December 8-10.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use